Oligoastrocytoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 10: Line 10:
===Genetics===
===Genetics===
*Development of oligoastrocytoma is the result of multiple [[mutation|genetic mutations]].
*Development of oligoastrocytoma is the result of multiple [[mutation|genetic mutations]].
*Oligoastrocytomas are mixed tumors that have molecular genetics that overlap with both [[oligodendrogliomas]] and [[astrocytomas]].
*Oligoastrocytomas are mixed tumors that have overlapping molecular genetics with both [[oligodendrogliomas]] and [[astrocytomas]].<ref name="pmid12107116">{{cite journal| author=Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J et al.| title=Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. | journal=Am J Pathol | year= 2002 | volume= 161 | issue= 1 | pages= 313-9 | pmid=12107116 | doi=10.1016/S0002-9440(10)64183-1 | pmc=PMC1850690 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12107116  }} </ref>
*Genes associated with the pathogenesis of oligoastrocytoma include:
*Genes associated with the pathogenesis of oligoastrocytoma include:
:*''[[Isocitrate dehydrogenase|IDH1]]''
:*''[[Isocitrate dehydrogenase|IDH1]]''

Revision as of 15:15, 16 October 2015

Oligoastrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligoastrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligoastrocytoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligoastrocytoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligoastrocytoma pathophysiology

CDC on Oligoastrocytoma pathophysiology

Oligoastrocytoma pathophysiology in the news

Blogs on Oligoastrocytoma pathophysiology

Directions to Hospitals Treating Glioma

Risk calculators and risk factors for Oligoastrocytoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Pathophysiology

Pathogenesis

Genetics

  • Development of oligoastrocytoma is the result of multiple genetic mutations.
  • Oligoastrocytomas are mixed tumors that have overlapping molecular genetics with both oligodendrogliomas and astrocytomas.[1]
  • Genes associated with the pathogenesis of oligoastrocytoma include:

Gross Pathology

  • On gross pathology, oligoastrocytoma is characterized by

Gallery

Microscopic Pathology

On microscopic histopathological analysis, oligoastrocytoma is characterized by:


On microscopic histopathological analysis, anaplastic oligoastrocytoma is characterized by:

Gallery

Immunohistochemistry

Oligoastrocytoma is demonstrated by positivity to tumor markers such as:[2]

References

  1. Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J; et al. (2002). "Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets". Am J Pathol. 161 (1): 313–9. doi:10.1016/S0002-9440(10)64183-1. PMC 1850690. PMID 12107116.
  2. IHC of oligoastrocytoma. Librepathology 2015. http://librepathology.org/wiki/index.php/Oligoastrocytoma. Accessed on October 16, 2015


Template:WikiDoc Sources